
Amgen Stock: Cancer Portfolio & Pipeline Make It A Buy (NASDAQ:AMGN)
Mohammed Haneefa Nizamudeen/iStock via Getty Images Amgen (NASDAQ:AMGN) is one of the best established of the biotechnology companies. Founded in 1980, in 1989, it received FDA approval for the first recombinant anemia therapy, Epogen. For […]